Cargando…

New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches

Antiphospholipid Syndrome (APS) is an autoimmune disorder, characterized by pregnancy morbidity and/or a hyper coagulable state involving the venous or the arterial vasculature and associated with antiphospholipid antibodies (aPL), including anti-cardiolipin antibodies (aCL), anti-beta2-glycoprotein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopez-Pedrera, Chary, Barbarroja, Nuria, Patiño-Trives, Alejandra Mª, Collantes, Eduardo, Aguirre, Mª Angeles, Perez-Sanchez, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476988/ https://www.ncbi.nlm.nih.gov/pubmed/31040845 http://dx.doi.org/10.3389/fimmu.2019.00764

Ejemplares similares

Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders
por: Lopez-Pedrera, Chary, et al.
Publicado: (2020)

Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis
por: Lopez-Pedrera, Chary, et al.
Publicado: (2020)

Therapeutic Potential and Immunomodulatory Role of Coenzyme Q(10) and Its Analogues in Systemic Autoimmune Diseases
por: López-Pedrera, Chary, et al.
Publicado: (2021)

‘Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients’
por: Pérez-Sánchez, C., et al.
Publicado: (2016)

Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk
por: Barbarroja, Nuria, et al.
Publicado: (2022)

Expression of DDX11 and DNM1L at the 12p11 Locus Modulates Systemic Lupus Erythematosus Susceptibility
por: Saeed, Mohammad, et al.
Publicado: (2021)

Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis
por: Luque-Tévar, Maria, et al.
Publicado: (2021)

Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis
por: Ruiz-Limon, Patricia, et al.
Publicado: (2019)

Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Proinflammatory Cytokines and Therapeutic Approaches
por: López-Pedrera, Chary, et al.
Publicado: (2010)

Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion
por: Pérez‐Sánchez, Carlos, et al.
Publicado: (2019)

Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome
por: Pérez-Sánchez, Carlos, et al.
Publicado: (2018)

Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs
por: Arias de la Rosa, Iván, et al.
Publicado: (2021)

Characterization of the inflammatory proteome of synovial fluid from patients with psoriatic arthritis: Potential treatment targets
por: Barbarroja, Nuria, et al.
Publicado: (2023)

Editorial: Clinical management, pathogenesis and biomarkers of cardiovascular disease associated with systemic autoimmune disorders
por: Perez-Sanchez, Carlos, et al.
Publicado: (2022)

Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα
por: Castro-Villegas, Carmen, et al.
Publicado: (2015)

Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis
por: Arias de la Rosa, Iván, et al.
Publicado: (2020)

Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies
por: de la Rosa, Ivan Arias, et al.
Publicado: (2020)

C-Reactive Protein in Atherothrombosis and Angiogenesis
por: Badimon, Lina, et al.
Publicado: (2018)

Clinical Utility of microRNAs in Exhaled Breath Condensate as Biomarkers for Lung Cancer
por: Pérez-Sánchez, Carlos, et al.
Publicado: (2021)

Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission
por: Aranda-Valera, Inmaculada Concepción, et al.
Publicado: (2020)

Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy
por: Ibáñez-Costa, Alejandro, et al.
Publicado: (2022)

The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast
por: Arias de la Rosa, Ivan, et al.
Publicado: (2022)

Cardiovascular Risk in Systemic Autoimmune Diseases: Epigenetic Mechanisms of Immune Regulatory Functions
por: López-Pedrera, Chary, et al.
Publicado: (2012)

Platelet-Derived Exosomes and Atherothrombosis
por: Wei, Kangkang, et al.
Publicado: (2022)

Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis
por: Barbarroja, Nuria, et al.
Publicado: (2019)

Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-α therapy effectiveness
por: Ruiz-Limon, Patricia, et al.
Publicado: (2020)

Cell Stress Proteins in Atherothrombosis
por: Madrigal-Matute, Julio, et al.
Publicado: (2012)

Potential Role and Impact of Peripheral Blood Mononuclear Cells in Radiographic Axial Spondyloarthritis-Associated Endothelial Dysfunction
por: Ruiz-Limon, Patricia, et al.
Publicado: (2021)

Progression from High Insulin Resistance to Type 2 Diabetes Does Not Entail Additional Visceral Adipose Tissue Inflammation
por: Barbarroja, Nuria, et al.
Publicado: (2012)

Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic Concepts
por: Levy, Roger A., et al.
Publicado: (2015)

Atherothrombosis: Pathogenesis of Cardiovascular Disease
por: Mojca, Stegnar
Publicado: (2003)

Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added
por: Liu, Xiangjun, et al.
Publicado: (2022)

Extracellular vesicles in atherothrombosis: From biomarkers and precision medicine to therapeutic targets
por: Badimon, Lina, et al.
Publicado: (2022)

High-throughput sequencing technology facilitates the discovery of novel biomarkers for antiphospholipid syndrome
por: Liu, Qi, et al.
Publicado: (2023)

Platelet thrombin receptor antagonism and atherothrombosis
por: Angiolillo, Dominick J., et al.
Publicado: (2010)

Atherothrombosis is a Thrombotic, not Inflammatory Disease
por: Sloop, Gregory D, et al.
Publicado: (2017)

Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis
por: Suades, Rosa, et al.
Publicado: (2022)

Review of Prasugrel for the Secondary Prevention of Atherothrombosis
por: Spinler, Sarah A., et al.
Publicado: (2009)

Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)

Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review
por: Pires da Rosa, Gilberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_isb0r6esriro7baqababv1dajl